期刊文献+

异基因造血干细胞移植后红系恢复影响因素分析 被引量:2

Factors in erythrocyte recovery following allogeneic hematopoietic stem cell transplantation
下载PDF
导出
摘要 目的探讨异基因造血干细胞移植后影响红系恢复时间的因素。方法回顾分析53例异基因造血干细胞移植患者的移植方式、人血细胞抗原(HLA)相合与否、ABO血型相合与否及亲缘关系的有无对红系恢复时间的影响。结果影响红系恢复时间的因素主要为ABO血型主要不合及受、供者的亲缘关系。结论ABO血型主要不合和非亲缘骨髓移植的患者红系恢复较慢。 Objective To investigate various factors influencing erythrecyte recovery following allogeneic hematopoietic stem cell transplantation(Allo-HSCT). Methods A retrospective study was performed to investigate factors including schemes of transplantation, HLA-matched or mismatched, ABO-incompatible or compatible, the relationship of the patient and donor that influenced erythrecyte recovery following Allo-HSCT. Results Major ABO-incompatible and the relationship of the patient and donor influenced the erythrocyte recovery. Conclusion The erythrecyte recovery is slower in patients with major ABO-incompatible transplantation and unrelated bone marrow transplantation.
出处 《中国医药》 2007年第10期598-599,共2页 China Medicine
关键词 造血系疾病 异基因造血干细胞移植 红细胞 Hemopoietic system disease Allogeneic hematopoietic stem cell transplantation Erythrecyte
  • 相关文献

参考文献2

二级参考文献2

共引文献49

同被引文献26

  • 1达万明,黄文荣.造血干细胞移植与输血[J].中国实用内科杂志,2004,24(9):521-522. 被引量:4
  • 2何舒杰,苏志强,薛嘉泓.成份输血在儿童急性白血病治疗与造血干细胞移植中的应用[J].中国小儿血液,2005,10(5):222-223. 被引量:2
  • 3张伟东,戎霞,叶欣,罗广平.造血干细胞移植同种免疫抗体对血小板输注的影响[J].中国输血杂志,2007,20(1):24-25. 被引量:1
  • 4Benkerrou M, Jais JP, Leblond V, et al. Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lympboproliferative disorder: prognostic factors and long-term outcome [ J ]. Blood, 1998, 92(9) :3137-3147.
  • 5Small TN, Papadopoulos EB, Boulad F, et al. Comparison of immune reconstitution after unrelated and related T-cell depleted bone marrow transplantation:effect of patient age and donor leukocyte infusions[ J ]. Blood, 1999,93 (2) :467-480.
  • 6Rooney CM,Smith CA, Ng CY,et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus induced lymphoma in allogeneie transplant recipients [ J ]. Blood, 1998,92 ( 5 ) : 1549-1555.
  • 7Comoli P,Labirio M,Basso S,et al. Infusion of autologous Epstein- Barr Virus(EBV) -specific eytotoxie T cell for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication [ J ]. Blood, 2002,99 ( 7 ) : 2592-2598.
  • 8Greiner T, Armitage JO, Gross TG. Atypical lymphoproliferative disease[ J]. Hematology ( Am Soc Hematol Educ Program) ,2000,1 ( 1 ) : 133-146.
  • 9Dharnidharka VR ,Tejani AH, Ho PL, et al. Post-transplant lympho- proliferative disorder in the United States: young Caucasian males are at highest risk[J]. Am J Transp lant,2002,2(10) :993-998.
  • 10Curtis RE, Travis LB, Rowlings PA, et al. Risk of lymphoproliferatire disorders after bone marrow transplantation:a multi-institutional study[J]. Blood, 1999,94 (7) :2208-2216.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部